由低剂量巴克洛芬引起的中央睡眠呼吸暂停:一个病例报告
Xiaoqiong Luo1,2, Qidi Ding3, Yanan Liu2
1Department of Encephalopathy, Chongqing Traditional Chinese Medicine Hospital, Chongqing, 400021, China.
Journal of medical case reports
|March 13, 2025
概括
巴克洛芬,用于肌肉,即使在低剂量也可能导致中央睡眠呼吸暂停. 停止服用巴克洛芬解决了这种情况,突出了呼吸系统监测的需要.
科学领域:
- 神经学 神经学
- 睡眠医学 睡眠医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 巴克洛芬是一种肌肉放松剂,可以抑制脊柱反射.
- 对神经疾病的非标签使用巴克洛芬正在增加.
- 巴克洛芬的使用与并发症的增加有关.
研究的目的:
- 报告一个由低剂量巴克洛芬引起的中央睡眠呼吸暂停病例.
- 为了突出巴克洛芬的潜在呼吸系统不良影响.
- 强调在巴克洛芬治疗期间监测呼吸功能的重要性.
主要方法:
- 一个60岁的女性患者的病例报告.
- 患者出现了夜间窒息和白天嗜睡.
- 多睡眠学被用来诊断中央睡眠呼吸暂停.
主要成果:
- 在开始低剂量巴克洛芬 (20毫克/天) 后,发现了中央睡眠呼吸暂停.
- 巴克洛芬取消导致中央睡眠呼吸暂停完全消失.
- 这些发现表明巴克洛芬和中央睡眠呼吸暂停之间存在因果关系.
结论:
- 巴克洛芬可以对呼吸控制产生不利影响,即使是低剂量.
- 建议在服用巴克洛芬之前和之后定期进行多睡眠扫描.
- 提高对巴克洛芬呼吸系统副作用的认识对于患者安全至关重要.
相关概念视频
Sleep Apnea
120
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
120
CNS Depressants: Barbiturates and Benzodiazepines
199
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
199
Sleepwalking and Sleep Talking
108
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
108
Narcolepsy
84
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
84
REM Sleep Behavior Disorder
127
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
127
Sedatives and Hypnotics Drugs: Miscellaneous Agents
143
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
143


